Skip to main content
. Author manuscript; available in PMC: 2010 Jun 9.
Published in final edited form as: Science. 2003 Apr 10;300(5620):767–772. doi: 10.1126/science.1083423

Fig. 5.

Fig. 5

The distribution of 1570 cytogenetic rearrangement breakpoints (850 constitutional and 720 malignancy-associated) from 1440 patients with defined phenotypes; 440 rearrangement breakpoints have been characterized at the molecular level for disease identification studies (7).